GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VivoSim Labs Inc (LTS:0R02) » Definitions » Days Sales Outstanding

VivoSim Labs (LTS:0R02) Days Sales Outstanding : 104.56 (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is VivoSim Labs Days Sales Outstanding?

VivoSim Labs's average Accounts Receivable for the three months ended in Dec. 2024 was $0.03 Mil. VivoSim Labs's Revenue for the three months ended in Dec. 2024 was $0.02 Mil. Hence, VivoSim Labs's Days Sales Outstanding for the three months ended in Dec. 2024 was 104.56.

The historical rank and industry rank for VivoSim Labs's Days Sales Outstanding or its related term are showing as below:

LTS:0R02' s Days Sales Outstanding Range Over the Past 10 Years
Min: 39.09   Med: 63.75   Max: 309.75
Current: 101.12

During the past 13 years, VivoSim Labs's highest Days Sales Outstanding was 309.75. The lowest was 39.09. And the median was 63.75.

LTS:0R02's Days Sales Outstanding is ranked worse than
69.43% of 844 companies
in the Biotechnology industry
Industry Median: 69.395 vs LTS:0R02: 101.12

VivoSim Labs's Days Sales Outstanding declined from Dec. 2023 (803.00) to Dec. 2024 (104.56).


VivoSim Labs Days Sales Outstanding Historical Data

The historical data trend for VivoSim Labs's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VivoSim Labs Days Sales Outstanding Chart

VivoSim Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.03 - - 149.95 309.75

VivoSim Labs Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 803.00 103.84 94.76 117.10 104.56

Competitive Comparison of VivoSim Labs's Days Sales Outstanding

For the Biotechnology subindustry, VivoSim Labs's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VivoSim Labs's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VivoSim Labs's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where VivoSim Labs's Days Sales Outstanding falls into.


;
;

VivoSim Labs Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

VivoSim Labs's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

Days Sales Outstanding (A: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (0.152 + 0.033) / 2 ) / 0.109*365
=0.0925 / 0.109*365
=309.75

VivoSim Labs's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding (Q: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2024 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (0.029 + 0.026) / 2 ) / 0.024*365 / 4
=0.0275 / 0.024*365 / 4
=104.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


VivoSim Labs  (LTS:0R02) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


VivoSim Labs Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of VivoSim Labs's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


VivoSim Labs Business Description

Traded in Other Exchanges
Address
11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

VivoSim Labs Headlines

No Headlines